Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Lyme disease controversies continue.

Charles S Pavia1

  • 1Department of Microbiology, New York College of Osteopathic Medicine of New York Institute of Technology, Old Westbury, New York 11568, USA. cpavia@iris.nyit.edu

Expert Opinion on Investigational Drugs
|October 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 vaccines for high risk and immunocompromised patients.

Methods in microbiology·2024
Same author

Hesitancy to get vaccinated against COVID-19 and how it might be overcome.

Methods in microbiology·2024
Same author

An Unusual Case of Serologically Confirmed Post-Partum Lyme Disease Following an Asymptomatic <i>Borrelia burgdorferi</i> Infection Acquired during Pregnancy and Lacking Vertical Transmission in Utero.

Pathogens (Basel, Switzerland)·2024
Same author

The major epidemiologic, microbiologic, immunologic, and clinical aspects of Lyme disease that form the basis for a newly developed vaccine that may become available soon for human use.

Frontiers in immunology·2024
Same author

Lessons learned from the successful polio vaccine experience not learned or applied with the development and implementation of the COVID-19 vaccines.

Current opinion in immunology·2023
Same author

Use of the Western blot technique to identify the immunogenic proteins of Borrelia burgdorferi for developing a Lyme disease vaccine.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2022

This article addresses ongoing debates in Lyme disease diagnosis and treatment, refuting unsubstantiated criticisms with peer-reviewed evidence. It clarifies key aspects of Lyme disease epidemiology and microbiology, including

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Epidemiology

Background:

  • Lyme disease diagnosis, patient management, and treatment remain contentious topics within both medical and public spheres.
  • Previous therapeutic recommendations for Lyme disease have faced criticism, often based on speculative theories rather than empirical data.
  • This response addresses specific criticisms by presenting evidence from the peer-reviewed literature.

Discussion:

  • Critiques of Lyme disease therapy frequently lack robust scientific backing, relying on anecdotal reports and unverified findings.
  • The author counters these criticisms by referencing extensive peer-reviewed research.
  • Inconsistencies in the understanding of Lyme disease epidemiology and microbiology, particularly concerning 'cyst forms', impact therapeutic strategies.

Key Insights:

Related Experiment Videos

  • Compelling evidence from published literature refutes many criticisms regarding Lyme disease therapy.
  • The role of 'cyst forms' in Borrelia burgdorferi (the causative agent of Lyme disease) requires further clarification.
  • A data-driven approach is essential for resolving disputes in Lyme disease management.

Outlook:

  • Further research is needed to reconcile differing perspectives on Lyme disease treatment.
  • Clarification of Lyme disease microbiology and epidemiology will inform evidence-based clinical guidelines.
  • Promoting a consensus based on scientific evidence is crucial for improving patient care.